As tested by both in vitro studies, Imperatorin (1–100 μm) could restrict angiotensin II-induced cardiac myocyte protein production, modulate pathological myocardial hypertrophy, pathological cardiac fibrosis, and prevent heart failure [92]. This evidence concerns the gene AGT and heart failure.